nafamostat mesilate

Known as: Nafamostat Dimethanesulfonate, Nafamostat Mesylate, 6-Amidino2-naphthyl 4-guanidinobenzoate 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Postreperfusion syndrome (PRS), an acute decrease in blood pressure after reperfusion of the liver graft, occurs frequently… (More)
Is this relevant?
2009
2009
PURPOSE Gemcitabine is currently the standard first-line chemotherapeutic agent for pancreatic cancer. However, chemoresistance… (More)
Is this relevant?
2009
2009
A 65-year-old man with chronic aortic dissection experienced two massive subcutaneous hemorrhages. Laboratory data indicated… (More)
Is this relevant?
2009
2009
AIMS The incidence of complications associated with cerebrovascular diseases in patients who receive hemodialysis for a long-term… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2006
2006
The pruritogenic potency of tryptase and its involvement in anti-pruritic effect of intravenous nafamostat mesilate (NFM) were… (More)
Is this relevant?
2006
2006
OBJECTIVE Mast cell tryptase has been proposed to be involved in the pathogenesis of human inflammatory bowel disease (IBD… (More)
Is this relevant?
2004
2004
Nafamostat mesilate (NM) is a serine-protease inhibitor that is rapidly eliminated from the circulation and accumulated in the… (More)
Is this relevant?
2003
2003
Previously, nafamostat mesilate was found to be a potent inhibitor of human tryptase. In present study, we performed a kinetic… (More)
  • figure 1
  • table 1
Is this relevant?
2003
2003
Nafamostat mesilate (NM), a clinically used serine protease inhibitor, suppressed the overproduction of nitric oxide (NO) and the… (More)
Is this relevant?
1994
1994
Nafamostat mesilate (NM), a synthetic protease inhibitor, is frequently used for the treatment of disseminated intravascular… (More)
Is this relevant?